Patents by Inventor Subinay Ganguly

Subinay Ganguly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Producing Anti-TNF Antibody Compositions
    Publication number: 20220153829
    Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: February 26, 2020
    Publication date: May 19, 2022
    Applicant: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith
  • Manufacturing Methods for Producing Anti-TNF Antibody Compositions
    Publication number: 20220153830
    Abstract: The present invention relates to methods of manufacture for producing anti-TNF antibodies, e.g., the anti-TNF antibody a recombinant anti-TNF antibody having a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: February 26, 2020
    Publication date: May 19, 2022
    Applicant: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith
  • Methods for Producing Anti-TNF Antibody Compositions
    Publication number: 20220144934
    Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: February 26, 2020
    Publication date: May 12, 2022
    Applicant: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith
  • Manufacturing Methods for Producing Anti-IL12/IL23 Antibody Compositions
    Publication number: 20200291107
    Abstract: Methods of manufacture for producing anti-IL-12/IL-23p40 antibodies, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, in CHO and specific pharmaceutical compositions of the antibody are useful in treating various diseases.
    Type: Application
    Filed: March 12, 2020
    Publication date: September 17, 2020
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith
  • FULLY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB
    Publication number: 20190062445
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Application
    Filed: September 20, 2018
    Publication date: February 28, 2019
    Inventors: Maria Jure-Kunkel, Laura J. Hefta, Marc Santoro, Subinay Ganguly, Edward L. Halk
  • FULLY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB
    Publication number: 20160368998
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Application
    Filed: June 6, 2016
    Publication date: December 22, 2016
    Inventors: Maria JURE-KUNKEL, Laura J. Hefta, Marc Santoro, Subinay Ganguly, Edward L. Halk
  • Fully human antibodies against human 4-1BB
    Patent number: 9382328
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: July 5, 2016
    Assignee: Bristol-Myers Squibb Company
    Inventors: Maria Jure-Kunkel, Laura J. Hefta, Marc Santoro, Subinay Ganguly, Edward L. Halk
  • FULLY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB
    Publication number: 20140193422
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Application
    Filed: March 14, 2014
    Publication date: July 10, 2014
    Inventors: Maria Jure-Kunkel, Laura J. Hefta, Marc Santoro, Subinay Ganguly, Edward L. Halk
  • Fully human antibodies against human 4-1BB
    Patent number: 8716452
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Grant
    Filed: February 8, 2012
    Date of Patent: May 6, 2014
    Assignee: Bristol-Myers Squibb Company
    Inventors: Maria Jure-Kunkel, Laura J. Hefta, Marc Santoro, Subinay Ganguly, Edward L. Halk
  • FULLY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB
    Publication number: 20120141494
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Application
    Filed: February 8, 2012
    Publication date: June 7, 2012
    Inventors: Maria Jure-Kunkel, Laura J. Hefta, Marc Santoro, Subinay Ganguly, Edward L. Halk
  • Fully human antibodies against human 4-1BB
    Patent number: 8137667
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Grant
    Filed: December 9, 2009
    Date of Patent: March 20, 2012
    Assignee: Bristol-Myers Squibb Company
    Inventors: Maria Jure-Kunkel, Laura J. Hefta, Marc Santoro, Subinay Ganguly, Edward L. Halk
  • Fully human antibodies against human 4-1BB
    Publication number: 20100183621
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Application
    Filed: December 9, 2009
    Publication date: July 22, 2010
    Inventors: Maria Jure-Kunkel, Laura J. Hefta, Marc Santoro, Subinay Ganguly, Edward L. Halk
  • Polynucleotides encoding fully human antibodies against human 4-1BB
    Patent number: 7659384
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Grant
    Filed: September 20, 2007
    Date of Patent: February 9, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Maria Jure-Kunkel, Laura J. Hefta, Marc Santoro, Subinay Ganguly, Edward L. Halk
  • Fully human antibodies against human 4-1BB
    Publication number: 20090068192
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Application
    Filed: September 20, 2007
    Publication date: March 12, 2009
    Inventors: Maria Jure-Kunkel, Laura J. Hefta, Marc Santoro, Subinay Ganguly, Edward L. Halk
  • Fully human antibodies against human 4-1BB
    Patent number: 7288638
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: October 30, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Maria Jure-Kunkel, Laura J. Hefta, Marc Santoro, Subinay Ganguly, Edward L. Halk
  • Polynucleotides encoding humanized antibodies against human 4-1BB
    Patent number: 7214493
    Abstract: A humanized antibody that binds to human 4-1BB and that allows binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating cancer in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Grant
    Filed: March 7, 2005
    Date of Patent: May 8, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Maria Jure Kunkel, Subinay Ganguly, Ralph Abraham, Diane L. Hollenbaugh, Jill Rillema, Barbara Thorne, Walter W. Shuford, Robert S. Mittler
  • Polynucleotides encoding humanized antibodies against human 4-1BB
    Publication number: 20050202022
    Abstract: A humanized antibody that binds to human 4-1BB and that allows binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating cancer in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Application
    Filed: March 7, 2005
    Publication date: September 15, 2005
    Inventors: Maria Kunkel, Subinay Ganguly, Ralph Abraham, Diane Hollenbaugh, Jill Rillema, Barbara Thorne, Walter Shuford, Robert Mittler
  • Fully human antibodies against human 4-1BB
    Publication number: 20050095244
    Abstract: Fully human antibodies and antigen-binding portions thereof that bind to human 4-1BB and that allow binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating a disease in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Application
    Filed: October 8, 2004
    Publication date: May 5, 2005
    Inventors: Maria Jure-Kunkel, Laura Hefta, Marc Santoro, Subinay Ganguly
  • Humanized antibodies against human 4-1BB
    Patent number: 6887673
    Abstract: A humanized antibody that binds to human 4-1BB and that allows binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating cancer in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Grant
    Filed: July 30, 2003
    Date of Patent: May 3, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Maria Jure Kunkel, Subinay Ganguly, Ralph Abraham, Diane L. Hollenbaugh, Jill Rillema, Barbara Thorne, Walter W. Shuford, Robert S. Mittler
  • Humanized antibodies against human 4-1BB
    Publication number: 20040105855
    Abstract: A humanized antibody that binds to human 4-1BB and that allows binding of human 4-1BB to a human 4-1BB ligand. In one aspect, the antibody is an IgG4 antibody. Also provided is a method for treating cancer in a subject comprising administering a therapeutically effective amount of the antibody to said subject.
    Type: Application
    Filed: July 30, 2003
    Publication date: June 3, 2004
    Inventors: Maria Jure Kunkel, Subinay Ganguly, Ralph Abraham, Diane L. Hollenbaugh, Jill Rillema, Barbara Thorne, Walter W. Shuford, Robert S. Mittler